指南与共识技术与安全

基于证据等级系统的人工智能影像工具批判性评估

Critical Appraisal of Artificial Intelligence-Enabled Imaging Tools Using the Levels of Evidence System.
PubMed 文献 · AJNR Am J Neuroradiol · 2023-04-20

ASFNR/ASNR人工智能工作组提出基于证据质量、类型和数量的分层评估系统,用于评价AI影像工具全生命周期的技术与临床效力。该系统仿照医学证据等级,最高等级代表对患者照护和健康结局潜在影响的最强证据,旨在促进透明度并推动AI工具的安全有效临床部署。

要点

  • 评估AI影像工具需系统化审视其开发至实施的全生命周期证据。
  • 证据等级系统按证据质量、类型和数量分层,最高层为最强临床影响证据。
  • 该系统旨在促进AI工具开发的透明度和决策过程理解。

局限性

  • 原文为提案性文章,未报告具体验证数据或实际应用效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Clinical adoption of an artificial intelligence-enabled imaging tool requires critical appraisal of its life cycle from development to implementation by using a systematic, standardized, and objective approach that can verify both its technical and clinical efficacy. Toward this concerted effort, the ASFNR/ASNR Artificial Intelligence Workshop Technology Working Group is proposing a hierarchal evaluation system based on the quality, type, and amount of scientific evidence that the artificial intelligence-enabled tool can demonstrate for each component of its life cycle. The current proposal is modeled after the levels of evidence in medicine, with the uppermost level of the hierarchy showing the strongest evidence for potential impact on patient care and health care outcomes. The intended goal of establishing an evidence-based evaluation system is to encourage transparency, foster an understanding of the creation of artificial intelligence tools and the artificial intelligence decision-making process, and to report the relevant data on the efficacy of artificial intelligence tools that are developed. The proposed system is an essential step in working toward a more formalized, clinically validated, and regulated framework for the safe and effective deployment of artificial intelligence imaging applications that will be used in clinical practice.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Pham, Hill, Rauschecker, et al. Critical Appraisal of Artificial Intelligence-Enabled Imaging Tools Using the Levels of Evidence System. AJNR Am J Neuroradiol. 2023. PMID: 37080722. doi:10.3174/ajnr.A7850

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。